Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 36.20
-0.20 (-0.55%)
At close: Mar 27, 2026
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 85.01 million as of March 27, 2026. Its market cap has decreased by -15.42% in one year.
Market Cap
85.01M
Enterprise Value
69.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36.20
Market Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 85.01M, a decrease of -57.01%. That is a compound annual growth rate of -16.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 85.01M | -8.40% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | 197.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 125.51M |
| Active Biotech AB | 117.04M |
| Alligator Bioscience AB | 110.30M |
| Biovica International AB | 106.84M |
| Annexin Pharmaceuticals AB | 94.59M |
| Scandinavian ChemoTech AB | 89.60M |
| Alzinova AB | 86.79M |
| OncoZenge AB | 82.32M |